97 related articles for article (PubMed ID: 11101807)
21. Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.
Logg CR; Baranick BT; Lemp NA; Kasahara N
J Mol Biol; 2007 Jun; 369(5):1214-29. PubMed ID: 17498744
[TBL] [Abstract][Full Text] [Related]
22. Genistein, a protein tyrosine kinase inhibitor, suppresses the fusogenicity of Moloney murine leukemia virus envelope protein in XC cells.
Kubo Y; Ishimoto A; Amanuma H
Arch Virol; 2003 Oct; 148(10):1899-914. PubMed ID: 14551814
[TBL] [Abstract][Full Text] [Related]
23. Genome shuffling leads to rapid phenotypic improvement in bacteria.
Zhang YX; Perry K; Vinci VA; Powell K; Stemmer WP; del Cardayré SB
Nature; 2002 Feb; 415(6872):644-6. PubMed ID: 11832946
[TBL] [Abstract][Full Text] [Related]
24. Development of enzyme-linked immunosorbent assay for detecting antibodies to replication-competent murine leukemia virus.
Kim S; Park EJ; Yu SS; Kim S
J Virol Methods; 2004 Jun; 118(1):1-7. PubMed ID: 15158062
[TBL] [Abstract][Full Text] [Related]
25. Murine leukemia virus (MLV) replication monitored with fluorescent proteins.
Sliva K; Erlwein O; Bittner A; Schnierle BS
Virol J; 2004 Dec; 1():14. PubMed ID: 15610559
[TBL] [Abstract][Full Text] [Related]
26. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
28. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
[TBL] [Abstract][Full Text] [Related]
29. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
30. From the natural evolution to the genetic manipulation of the host-range of retroviruses.
Dornburg R
Biol Chem; 1997 Jun; 378(6):457-68. PubMed ID: 9224924
[TBL] [Abstract][Full Text] [Related]
31. Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication.
Pfeiffer JK; Telesnitsky A
J Virol; 2001 Dec; 75(23):11263-74. PubMed ID: 11689606
[TBL] [Abstract][Full Text] [Related]
32. A novel family of retroviral vectors for the rapid production of complex stable cell lines.
Schaefer BC; Mitchell TC; Kappler JW; Marrack P
Anal Biochem; 2001 Oct; 297(1):86-93. PubMed ID: 11567531
[TBL] [Abstract][Full Text] [Related]
33. Transduction of nondividing human macrophages with gammaretrovirus-derived vectors.
Jarrosson-Wuilleme L; Goujon C; Bernaud J; Rigal D; Darlix JL; Cimarelli A
J Virol; 2006 Feb; 80(3):1152-9. PubMed ID: 16414992
[TBL] [Abstract][Full Text] [Related]
34. High-titer packaging cells producing recombinant retroviruses resistant to human serum.
Cosset FL; Takeuchi Y; Battini JL; Weiss RA; Collins MK
J Virol; 1995 Dec; 69(12):7430-6. PubMed ID: 7494248
[TBL] [Abstract][Full Text] [Related]
35. Experimental and modelling study of different process modes for retroviral production in a fixed bed reactor.
Nehring D; Gonzalez R; Pörtner R; Czermak P
J Biotechnol; 2006 Mar; 122(2):239-53. PubMed ID: 16298006
[TBL] [Abstract][Full Text] [Related]
36. Effect of medium sugar source on the production of retroviral vectors for gene therapy.
Coroadinha AS; Ribeiro J; Roldão A; Cruz PE; Alves PM; Merten OW; Carrondo MJ
Biotechnol Bioeng; 2006 May; 94(1):24-36. PubMed ID: 16514678
[TBL] [Abstract][Full Text] [Related]
37. Redirecting retroviral tropism by insertion of hepatitis B virus PreS1 core peptide into the envelope.
Qi P; Han JX; Lu YQ; Wang CX
Arch Virol; 2007; 152(9):1721-30. PubMed ID: 17520321
[TBL] [Abstract][Full Text] [Related]
38. Engineering of a stable retroviral gene delivery vector by directed evolution.
Vu HN; Ramsey JD; Pack DW
Mol Ther; 2008 Feb; 16(2):308-14. PubMed ID: 17984974
[TBL] [Abstract][Full Text] [Related]
39. Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins.
Marin M; Noël D; Valsesia-Wittman S; Brockly F; Etienne-Julan M; Russell S; Cosset FL; Piechaczyk M
J Virol; 1996 May; 70(5):2957-62. PubMed ID: 8627771
[TBL] [Abstract][Full Text] [Related]
40. Evolution of a cytokine using DNA family shuffling.
Chang CC; Chen TT; Cox BW; Dawes GN; Stemmer WP; Punnonen J; Patten PA
Nat Biotechnol; 1999 Aug; 17(8):793-7. PubMed ID: 10429246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
